 MaxCyte Inc headed 5.8 higher to 1,100p after it granted a pile of options over 100,000 shares in aggregate to directors and officers of the company. The options have an exercise period of 10 years from date of grant, at which time they will expire, and have an exercise price equal to the closing price of MaxCytes stock on 9 August 2021, of US16.63. 